Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Human correlates of provocative questions in pancreatic pathology.

McDonald OG, Maitra A, Hruban RH.

Adv Anat Pathol. 2012 Nov;19(6):351-62. doi: 10.1097/PAP.0b013e318273f998. Review.

2.

Pancreatic cancer biology and genetics.

Bardeesy N, DePinho RA.

Nat Rev Cancer. 2002 Dec;2(12):897-909. Review.

PMID:
12459728
3.

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR.

PLoS One. 2012;7(10):e46514. doi: 10.1371/journal.pone.0046514. Epub 2012 Oct 19.

4.

The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma.

Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash S, Logsdon CD, Simeone DM.

Pancreas. 2004 Nov;29(4):254-63.

PMID:
15502640
5.

Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer.

Hwang RF, Moore TT, Hattersley MM, Scarpitti M, Yang B, Devereaux E, Ramachandran V, Arumugam T, Ji B, Logsdon CD, Brown JL, Godin R.

Mol Cancer Res. 2012 Sep;10(9):1147-57. Epub 2012 Aug 2.

6.

miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer.

Ren ZG, Dong SX, Han P, Qi J.

Oncol Rep. 2016 Mar;35(3):1365-74. doi: 10.3892/or.2015.4534. Epub 2015 Dec 29.

PMID:
26719072
7.

BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.

Kayed H, Bekasi S, Keleg S, Michalski CW, Giese T, Friess H, Kleeff J.

Mol Cancer. 2007 Dec 28;6:83. doi: 10.1186/1476-4598-6-83.

8.

Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis.

Cano CE, Hamidi T, Garcia MN, Grasso D, Loncle C, Garcia S, Calvo E, Lomberk G, Dusetti N, Bartholin L, Urrutia R, Iovanna JL.

Gut. 2014 Jun;63(6):984-95. doi: 10.1136/gutjnl-2013-305221. Epub 2013 Sep 11.

PMID:
24026351
9.

Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.

Sinha A, Cherba D, Bartlam H, Lenkiewicz E, Evers L, Barrett MT, Haab BB.

Mol Oncol. 2014 Oct;8(7):1253-65. doi: 10.1016/j.molonc.2014.04.007. Epub 2014 May 2.

10.

The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.

Skrypek N, Duchêne B, Hebbar M, Leteurtre E, van Seuningen I, Jonckheere N.

Oncogene. 2013 Mar 28;32(13):1714-23. doi: 10.1038/onc.2012.179. Epub 2012 May 14.

11.

E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.

Stark AP, Chang HH, Jung X, Moro A, Hertzer K, Xu M, Schmidt A, Hines OJ, Eibl G.

Surgery. 2015 Dec;158(6):1564-72. doi: 10.1016/j.surg.2015.07.023. Epub 2015 Aug 18.

12.

Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.

Proctor E, Waghray M, Lee CJ, Heidt DG, Yalamanchili M, Li C, Bednar F, Simeone DM.

PLoS One. 2013;8(2):e55820. doi: 10.1371/journal.pone.0055820. Epub 2013 Feb 20.

13.

Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.

Mohammad RM, Li Y, Mohamed AN, Pettit GR, Adsay V, Vaitkevicius VK, Al-Katib AM, Sarkar FH.

Pancreas. 1999 Nov;19(4):353-61.

PMID:
10547195
14.

The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.

Bardeesy N, Sharpless NE, DePinho RA, Merlino G.

Semin Cancer Biol. 2001 Jun;11(3):201-18. Review.

PMID:
11407945
15.

Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness.

Sato N, Maehara N, Su GH, Goggins M.

J Natl Cancer Inst. 2003 Feb 19;95(4):327-30.

PMID:
12591989
16.

Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells.

Zhang SN, Huang FT, Huang YJ, Zhong W, Yu Z.

Tumori. 2010 Nov-Dec;96(6):985-92.

17.

Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.

Feldmann G, Karikari C, dal Molin M, Duringer S, Volkmann P, Bartsch DK, Bisht S, Koorstra JB, Brossart P, Maitra A, Fendrich V.

Cancer Biol Ther. 2011 Jun 1;11(11):959-68. Epub 2011 Jun 1.

18.

HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).

Mehdi O, Françoise S, Sofia CL, Urs G, Kevin Z, Bernard S, Igor S, Anabela CD, Dominique L, Eric M, Ali O.

Pancreatology. 2012 Mar-Apr;12(2):146-55. doi: 10.1016/j.pan.2012.02.013. Epub 2012 Feb 25.

PMID:
22487525
19.

Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.

Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, Eshleman JR, Maitra A, Schulick R, Winter J, Ouellette MM, Goggins M, Hruban R.

Cancer Biol Ther. 2007 Mar;6(3):324-8. Epub 2007 Mar 24.

20.

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.

Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Penas EM, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Effenberger KE, Bockhorn M, Izbicki JR, Yekebas EF.

BMC Cancer. 2010 Jun 16;10:295. doi: 10.1186/1471-2407-10-295.

Supplemental Content

Support Center